Impact of COVID-19 on Overseas Sales, Performance and Accounting Estimates
First written in FY2021-Q1. 3 of 10 entries say "Worsened", first in FY2021-Q2. Latest entry: FY2024-Q3.
The whole theme swung hardest in 2026: 5 of 22 companies on the "Worse" side.
- FY2024-Q3MitigatedAnnual report
「Economic activity was moving toward normalisation following the easing of restrictions to control COVID-19. However, uncertainty about the outlook continued due to inflation caused by soaring resource prices, monetary tightening aimed at curbing inflation in various countries, stagnation in the Chinese economy, and heightened geopolitical risks related to the situations in Ukraine and the Middle East, among other factors.」
Economic activity was said to have moved toward normalization following the easing of COVID-19 restrictions, and the impact of the pandemic on the business environment had eased from the previous stage. Other external-environment risks, however, have continued. - FY2023-Q2MitigatedAnnual report
「Although the improvement in COVID-19 infection rates raised expectations for an economic recovery, the outlook remains uncertain due to rising geopolitical risks associated with the prolonged Russia-Ukraine situation and the rapid depreciation of the yen, among other factors.」
Expectations for an economic recovery following the improvement in COVID-19 infection rates were indicated, while geopolitical risks and the rapid depreciation of the yen have kept conditions uncertain. - FY2023-Q1WorsenedAnnual report
「Uncertainty about the outlook remains due to the continued spread of COVID-19, particularly variant strains, heightened geopolitical risks resulting from the prolonged Russia-Ukraine situation, and the rapid depreciation of the yen, among other factors.」
A resurgence of COVID-19 infections, particularly involving new variants, was identified as a source of uncertainty in the business environment. - FY2022-Q3RestatedAnnual report
「The OKI Group (the Company and its consolidated subsidiaries) has reflected in its accounting treatment certain accounting estimates, including the recoverability of deferred tax assets and the assessment of indications of impairment of fixed assets, based on the assumption that the impact of the spread of COVID-19 would continue for a certain period during the consolidated fiscal year. There has been no material change in this assumption from the previous consolidated fiscal year. However, the impact of the spread of COVID-19 involves many uncertainties, and future results may differ from these assumptions and estimates.」
Although there has been no material change from the previous fiscal year in the accounting assumption that the impact of the pandemic would continue for a certain period, the possibility that future results may differ from the assumption was reconfirmed. - FY2022-Q2RestatedAnnual report
「The OKI Group (the Company and its consolidated subsidiaries) has reflected in its accounting treatment certain accounting estimates, including the recoverability of deferred tax assets and the assessment of indications of impairment of fixed assets, based on the assumption that the impact of the spread of COVID-19 would continue for a certain period during the consolidated fiscal year. There has been no material change in this assumption from the previous consolidated fiscal year. However, the impact of the spread of COVID-19 involves many uncertainties, and future results may differ from these assumptions and estimates.」
Although there has been no material change from the previous fiscal year in the accounting assumption that the impact of the pandemic would continue for a certain period, the possibility that future results may differ from the assumption was reconfirmed. - FY2022-Q1RestatedAnnual report
「The OKI Group (the Company and its consolidated subsidiaries) has reflected in its accounting treatment certain accounting estimates, including the recoverability of deferred tax assets and the assessment of indications of impairment of fixed assets, based on the assumption that the impact of the spread of COVID-19 would continue for a certain period during the consolidated fiscal year. There has been no material change in this assumption from the previous consolidated fiscal year. However, the impact of the spread of COVID-19 involves many uncertainties, and future results may differ from these assumptions and estimates.」
Although there has been no material change from the previous fiscal year in the accounting assumption that the impact of the pandemic would continue for a certain period, the possibility that future results may differ was reconfirmed. - FY2021Full-year impact finalizedAnnual report
「In the consolidated fiscal year, the impact of COVID-19 was approximately ¥27.0 billion on net sales and approximately ¥6.5 billion on operating income, respectively, in each case a negative impact.」
The full-year negative impact of COVID-19 was disclosed as approximately ¥27.0 billion on net sales and approximately ¥6.5 billion on operating income. - FY2021-Q3WorsenedAnnual report
「In the cumulative consolidated period through the third quarter, the impact of COVID-19 was approximately ¥23.0 billion on net sales and approximately ¥7.0 billion on operating income, respectively, in each case a negative impact.」
The negative impact of COVID-19 expanded from approximately ¥16.5 billion on net sales and approximately ¥5.0 billion on operating income in the cumulative period through the second quarter to approximately ¥23.0 billion and approximately ¥7.0 billion, respectively. - FY2021-Q2WorsenedAnnual report
「In the cumulative consolidated period through the second quarter, the impact of COVID-19 was approximately ¥16.5 billion on net sales and approximately ¥5.0 billion on operating income, respectively, in each case a negative impact.」
The impact of COVID-19 continued, resulting in quantified negative impacts of approximately ¥16.5 billion on net sales and approximately ¥5.0 billion on operating income in the cumulative period through the second quarter. - FY2021-Q1MaterialisedAnnual report
「The COVID-19 pandemic had a negative impact of approximately ¥11 billion on net sales and approximately ¥2 billion on operating income during the cumulative first-quarter consolidated accounting period.」
The COVID-19 pandemic actually affected business performance through weak sales in overseas markets and other factors, resulting in quantified negative impacts of approximately ¥11 billion on net sales and approximately ¥2 billion on operating income. The assumption that the spread of the infection would continue was also reflected in accounting estimates, including the recoverability of deferred tax assets and the assessment of indicators of impairment of fixed assets.